Altitude Life Science Ventures

About The Fund

Altitude Life Science Ventures is a venture capital firm that's dedicated to propelling the frontiers of science and technology. Based in Kirkland, Washington, their expertise lies in nurturing early-stage life science companies. The fund specializes in a wide array of sectors within the life sciences realm including, but not limited to, protein and small molecule therapeutics, diagnostics, medical devices, industrial and chemical reactions, optical displays, agriculture or plant microbiome, and DNA sequencing. With a strong focus on breakthrough innovations in HealthTech, Biotech, A.I., and other technology-enhanced fields such as FinTech and Media, Altitude Life Science Ventures stands as a pillar for transformative ventures that aim to redefine industries and improve human well-being. Their investment strategy revolves around empowering entrepreneurs with bold visions by providing financial investments ranging from a minimum of $3,500,000 to a maximum of $75,000,000. They closely work with companies that demonstrate the potential for significant outcomes in both business success and contributions to society. By engaging with businesses at early stages, they aim to affect substantial influence and accelerate growth pathways, ushering these ventures from fledgling startups to heavyweight contenders in their respective fields. Additionally, their investment philosophy extends to supporting existing businesses poised for next-level scaling, fostering novel solutions, and commanding change. Their portfolio illustrates a commitment to a diverse collection of revolutionary enterprises that embody their investment thesis, showcasing a history of success stories that resonate across the investment management and entrepreneurial landscape.